Literature DB >> 8003052

Breast-feeding and the onset of rheumatoid arthritis.

P Brennan1, A Silman.   

Abstract

OBJECTIVE: In a recent study we demonstrated that the postpartum period, particularly after the first pregnancy, is a time of increased risk for the development of rheumatoid arthritis (RA). The present study was undertaken to investigate whether this risk might be explained by breast-feeding.
METHODS: Through a nationwide media campaign, we identified 187 women who had developed RA within 12 months of a pregnancy, and we compared their breast-feeding histories with those of 149 similarly aged women chosen from the patient registers of a nationwide group of general practitioners.
RESULTS: In all, 88 of the women with RA developed the disease after their first pregnancy. Eighty-one percent of these 88 women had breast-fed. This was higher than the breast-feeding prevalence of 50% in the 129 controls whose first pregnancy had resulted in a live birth (adjusted odds ratio [OR] 5.4, 95% confidence interval 2.5-11.4). There was a smaller increased risk of breast-feeding after a second pregnancy in the RA cases (OR 2.0) and no increase after a third pregnancy (OR 0.6). The increase in risk was greatest in those cases whose disease was erosive and who were rheumatoid factor positive.
CONCLUSION: In a small group of susceptible women, exposure to breast-feeding after the first pregnancy is associated with a significant increase in risk for RA development. We postulate that this may reflect hormonal influences, specifically the high level of the proinflammatory hormone prolactin.

Entities:  

Mesh:

Year:  1994        PMID: 8003052     DOI: 10.1002/art.1780370605

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  24 in total

1.  Maternal considerations in formulating HIV-related breast-feeding recommendations.

Authors:  P Zimmer; C Garza
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

2.  Why the gender difference in susceptibility to rheumatoid arthritis?

Authors:  P Brennan; A Silman
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

3.  Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis.

Authors:  C Jorgensen; M C Picot; C Bologna; J Sany
Journal:  Ann Rheum Dis       Date:  1996-02       Impact factor: 19.103

4.  Increased risk for clinical onset of myasthenia gravis during the postpartum period.

Authors:  Marion I Boldingh; Angelina H Maniaol; Cathrine Brunborg; Harald Weedon-Fekjær; Jan J G M Verschuuren; Chantal M E Tallaksen
Journal:  Neurology       Date:  2016-10-21       Impact factor: 9.910

5.  Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey.

Authors: 
Journal:  Clin Rheumatol       Date:  2016-12-19       Impact factor: 2.980

6.  Decreased prolactin response to hypoglycaemia in patients with rheumatoid arthritis: correlation with disease activity.

Authors:  A M M Eijsbouts; F H J van den Hoogen; R F J M Laan; C G J Sweep; A R M M Hermus; L B A van de Putte
Journal:  Ann Rheum Dis       Date:  2004-08-19       Impact factor: 19.103

Review 7.  The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Authors:  Carmen Clapp; Norma Adán; María G Ledesma-Colunga; Mariana Solís-Gutiérrez; Jakob Triebel; Gonzalo Martínez de la Escalera
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

8.  Influence of HLA-class II incompatibility between mother and fetus on the development and course of rheumatoid arthritis of the mother.

Authors:  I E van der Horst-Bruinsma; R R de Vries; P D de Buck; P W van Schendel; F C Breedveld; G M Schreuder; J M Hazes
Journal:  Ann Rheum Dis       Date:  1998-05       Impact factor: 19.103

Review 9.  Epidemiology and burden of illness of rheumatoid arthritis.

Authors:  Tore K Kvien
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 10.  Why are women predisposed to autoimmune rheumatic diseases?

Authors:  Jacqueline E Oliver; Alan J Silman
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.